Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geno Merli

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Hospital Practice (1995)|December 16, 2014
Facilitating anticoagulation for safer transitions: preliminary outcomes from an emergency department deep vein thrombosis discharge programLaura Falconieri, Lynda Thomson, Glenn Oettinger, et al.
Vascular Medicine (London, England)|June 10, 2026
Barriers and facilitators to implementation of hospital-wide venous thromboembolism risk assessment models: A scoping reviewDaniel S Cheah, Akshay Seenivasan, Chloé A Powell, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day periodSteven R Deitcher, Craig M Kessler, Geno Merli, et al.
The New England Journal of Medicine|November 15, 2011
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patientsSamuel Z Goldhaber, Alain Leizorovicz, Ajay K Kakkar, et al.
The Journal of Bone and Joint Surgery. American Volume|September 18, 2015
Thromboembolism After Intramedullary Nailing for Metastatic Bone LesionsBrandon Shallop, Alexandria Starks, Simon Greenbaum, et al.
Journal of the American College of Clinical Pharmacy : JACCP|April 6, 2021
Adaptation of clinical pharmacy services to meet patient care needs during the COVID-19 pandemicIlya M Danelich, Lynda Thomson, Judith Alberto, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 27, 2005
The physician-hospital team: a successful approach to improving care in a large academic medical centerArthur M Feldman, Howard Weitz, Geno Merli, et al.
Journal of Thrombosis and Thrombolysis|March 2, 2011
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocolAlexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, et al.
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
Global Spine Journal|November 23, 2017
Efficacy, Safety, and Timing of Anticoagulant Thromboprophylaxis for the Prevention of Venous Thromboembolism in Patients With Acute Spinal Cord Injury: A Systematic ReviewPaul M Arnold, James S Harrop, Geno Merli, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Hospital Practice (1995)|December 16, 2014
Facilitating anticoagulation for safer transitions: preliminary outcomes from an emergency department deep vein thrombosis discharge programLaura Falconieri, Lynda Thomson, Glenn Oettinger, et al.
Vascular Medicine (London, England)|June 10, 2026
Barriers and facilitators to implementation of hospital-wide venous thromboembolism risk assessment models: A scoping reviewDaniel S Cheah, Akshay Seenivasan, Chloé A Powell, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 27, 2006
Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day periodSteven R Deitcher, Craig M Kessler, Geno Merli, et al.
The New England Journal of Medicine|November 15, 2011
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patientsSamuel Z Goldhaber, Alain Leizorovicz, Ajay K Kakkar, et al.
The Journal of Bone and Joint Surgery. American Volume|September 18, 2015
Thromboembolism After Intramedullary Nailing for Metastatic Bone LesionsBrandon Shallop, Alexandria Starks, Simon Greenbaum, et al.
Journal of the American College of Clinical Pharmacy : JACCP|April 6, 2021
Adaptation of clinical pharmacy services to meet patient care needs during the COVID-19 pandemicIlya M Danelich, Lynda Thomson, Judith Alberto, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 27, 2005
The physician-hospital team: a successful approach to improving care in a large academic medical centerArthur M Feldman, Howard Weitz, Geno Merli, et al.
Journal of Thrombosis and Thrombolysis|March 2, 2011
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocolAlexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, et al.
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
Global Spine Journal|November 23, 2017
Efficacy, Safety, and Timing of Anticoagulant Thromboprophylaxis for the Prevention of Venous Thromboembolism in Patients With Acute Spinal Cord Injury: A Systematic ReviewPaul M Arnold, James S Harrop, Geno Merli, et al.
Pageof 4